Medpace Reports Q3 2026 Revenue of $716.0 Million, Updates 2026 Outlook
Medpace reported Q3 2026 EPS of $4.84 and revenue of $716.0 million, exceeding FactSet estimates of $4.44 and $714.5 million, respectively. It now expects full-year 2026 revenue of $2.84 billion to $2.86 billion and EPS of $17.97 to $18.32.